Nabriva Therapeutics PLC - ADR (NBRV) stock is down -64.40% over the last 12 months, and the average rating from Wall Street analysts is a Strong Sell. InvestorsObserver’s proprietary ranking system, gives NBRV stock a score of 29 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 21. NBRV's rank also includes a long-term technical score of 30. NBRV has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on NBRV!